OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS
Paul J. Hop, Ramona A.J. Zwamborn, Eilís Hannon, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 633
Open Access | Times Cited: 64
Paul J. Hop, Ramona A.J. Zwamborn, Eilís Hannon, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 633
Open Access | Times Cited: 64
Showing 1-25 of 64 citing articles:
Amyotrophic lateral sclerosis: translating genetic discoveries into therapies
Fulya Akçimen, Elia R. Lopez, John E. Landers, et al.
Nature Reviews Genetics (2023) Vol. 24, Iss. 9, pp. 642-658
Open Access | Times Cited: 105
Fulya Akçimen, Elia R. Lopez, John E. Landers, et al.
Nature Reviews Genetics (2023) Vol. 24, Iss. 9, pp. 642-658
Open Access | Times Cited: 105
Current State and Future Directions in the Therapy of ALS
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 55
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 55
Innate immune activation in neurodegenerative diseases
Sergio Castro‐Gomez, Michael T. Heneka
Immunity (2024) Vol. 57, Iss. 4, pp. 790-814
Closed Access | Times Cited: 15
Sergio Castro‐Gomez, Michael T. Heneka
Immunity (2024) Vol. 57, Iss. 4, pp. 790-814
Closed Access | Times Cited: 15
Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery
Satoru Morimoto, Shinichi Takahashi, Daisuke Ito, et al.
Cell stem cell (2023) Vol. 30, Iss. 6, pp. 766-780.e9
Open Access | Times Cited: 38
Satoru Morimoto, Shinichi Takahashi, Daisuke Ito, et al.
Cell stem cell (2023) Vol. 30, Iss. 6, pp. 766-780.e9
Open Access | Times Cited: 38
The amyotrophic lateral sclerosis exposome: recent advances and future directions
Stephen A. Goutman, Masha G. Savelieff, Dae-Gyu Jang, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 10, pp. 617-634
Open Access | Times Cited: 36
Stephen A. Goutman, Masha G. Savelieff, Dae-Gyu Jang, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 10, pp. 617-634
Open Access | Times Cited: 36
Nutritional and metabolic factors in amyotrophic lateral sclerosis
Albert C. Ludolph, Luc Dupuis, Edward J. Kasarskis, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 9, pp. 511-524
Closed Access | Times Cited: 29
Albert C. Ludolph, Luc Dupuis, Edward J. Kasarskis, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 9, pp. 511-524
Closed Access | Times Cited: 29
L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review
Wenbo Wang, Da Pan, Qi Liu, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1232-1232
Open Access | Times Cited: 10
Wenbo Wang, Da Pan, Qi Liu, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1232-1232
Open Access | Times Cited: 10
Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy
Christian Griñán‐Ferré, Aina Bellver‐Sanchís, Ana Guerrero, et al.
Pharmacological Research (2024) Vol. 205, pp. 107247-107247
Open Access | Times Cited: 8
Christian Griñán‐Ferré, Aina Bellver‐Sanchís, Ana Guerrero, et al.
Pharmacological Research (2024) Vol. 205, pp. 107247-107247
Open Access | Times Cited: 8
Lipids shape brain function through ion channel and receptor modulations: physiological mechanisms and clinical perspectives
Salvatore Incontro, Maria Laura Musella, Malika Sammari, et al.
Physiological Reviews (2024) Vol. 105, Iss. 1, pp. 137-207
Closed Access | Times Cited: 6
Salvatore Incontro, Maria Laura Musella, Malika Sammari, et al.
Physiological Reviews (2024) Vol. 105, Iss. 1, pp. 137-207
Closed Access | Times Cited: 6
Whole-genome bisulfite sequencing of cell-free DNA unveils age-dependent and ALS-associated methylation alterations
Yulin Jin, Karen N. Conneely, Wenjing Ma, et al.
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Yulin Jin, Karen N. Conneely, Wenjing Ma, et al.
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
Juan M. Godoy-Corchuelo, Luis C. Fernández-Beltrán, Zeinab Ali, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1105-1105
Open Access | Times Cited: 22
Juan M. Godoy-Corchuelo, Luis C. Fernández-Beltrán, Zeinab Ali, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1105-1105
Open Access | Times Cited: 22
Integrated methylome and phenome study of the circulating proteome reveals markers pertinent to brain health
Danni A. Gadd, Robert F. Hillary, Daniel L. McCartney, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Danni A. Gadd, Robert F. Hillary, Daniel L. McCartney, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Tissue informative cell-free DNA methylation sites in amyotrophic lateral sclerosis
Christa Caggiano, Marco Morselli, Xia Qian, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Christa Caggiano, Marco Morselli, Xia Qian, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis
Calum Harvey, Marcel Weinreich, James Lee, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24975-e24975
Open Access | Times Cited: 4
Calum Harvey, Marcel Weinreich, James Lee, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24975-e24975
Open Access | Times Cited: 4
Larsucosterol: endogenous epigenetic regulator for treating chronic and acute liver diseases
Yaping Wang, Jenna Ren, Shunlin Ren
AJP Endocrinology and Metabolism (2024) Vol. 326, Iss. 5, pp. E577-E587
Open Access | Times Cited: 4
Yaping Wang, Jenna Ren, Shunlin Ren
AJP Endocrinology and Metabolism (2024) Vol. 326, Iss. 5, pp. E577-E587
Open Access | Times Cited: 4
The epigenetic modification of DNA methylation in neurological diseases
Linke Li, R Chen, Hui Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Linke Li, R Chen, Hui Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis
Kiterie M. E. Faller, Helena Chaytow, Thomas H. Gillingwater
Nature Reviews Neurology (2025) Vol. 21, Iss. 2, pp. 86-102
Closed Access
Kiterie M. E. Faller, Helena Chaytow, Thomas H. Gillingwater
Nature Reviews Neurology (2025) Vol. 21, Iss. 2, pp. 86-102
Closed Access
The Promise of Epigenetic Editing for Treating Brain Disorders
Luis Alfonso González-Molina, Amalia M. Dolga, Marianne G. Rots, et al.
Sub-cellular biochemistry/Subcellular biochemistry (2025), pp. 111-190
Closed Access
Luis Alfonso González-Molina, Amalia M. Dolga, Marianne G. Rots, et al.
Sub-cellular biochemistry/Subcellular biochemistry (2025), pp. 111-190
Closed Access
Epigenetics in Neurodegenerative Diseases
Brigitte van Zundert, Martı́n Montecino
Sub-cellular biochemistry/Subcellular biochemistry (2025), pp. 73-109
Closed Access
Brigitte van Zundert, Martı́n Montecino
Sub-cellular biochemistry/Subcellular biochemistry (2025), pp. 73-109
Closed Access
Transforming Neurodegenerative Disorder Care with Machine Learning: Strategies and Applications
Aya Galal, Ahmed A. Moustafa, Mohamed Salama
(2025)
Closed Access
Aya Galal, Ahmed A. Moustafa, Mohamed Salama
(2025)
Closed Access
Epigenetic regulation of TDP-43: potential implications for amyotrophic lateral sclerosis
D. Y. Mengistu, Monica Terribili, C. Pellacani, et al.
Frontiers in Molecular Medicine (2025) Vol. 5
Open Access
D. Y. Mengistu, Monica Terribili, C. Pellacani, et al.
Frontiers in Molecular Medicine (2025) Vol. 5
Open Access
Transforming neurodegenerative disorder care with machine learning: Strategies and applications
Aya Galal, Ahmed A. Moustafa, Mohamed Salama
Neuroscience (2025)
Closed Access
Aya Galal, Ahmed A. Moustafa, Mohamed Salama
Neuroscience (2025)
Closed Access
MethPriorGCN: a deep learning tool for inferring DNA methylation prior knowledge and guiding personalized medicine
Jie Ni, Bin Li, Shumei Miao, et al.
Briefings in Bioinformatics (2025) Vol. 26, Iss. 2
Open Access
Jie Ni, Bin Li, Shumei Miao, et al.
Briefings in Bioinformatics (2025) Vol. 26, Iss. 2
Open Access
The Role of Sphingomyelin and Ceramide in Motor Neuron Diseases
Gavin McCluskey, Colette Donaghy, Karen Morrison, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1418-1418
Open Access | Times Cited: 21
Gavin McCluskey, Colette Donaghy, Karen Morrison, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1418-1418
Open Access | Times Cited: 21
Effects of PB‐TURSO on the transcriptional and metabolic landscape of sporadic ALS fibroblasts
Jasmine A. Fels, Jalia Dash, Kent Leslie, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 10, pp. 1551-1564
Open Access | Times Cited: 21
Jasmine A. Fels, Jalia Dash, Kent Leslie, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 10, pp. 1551-1564
Open Access | Times Cited: 21
